The US Food and Drug Administration has yet to take a firm position on either CBD or probiotics in cosmetics, but advises companies to take a cautious approach to the ingredients’ use.
Presenting May 9 at the Independent Cosmetic Manufacturers and Distributors’ 38th annual regulatory workshop in New York, Linda Katz, director...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?